Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
暂无分享,去创建一个
E. Benchimol | G. Nguyen | Glenys A. Smith | M. Carrier | S. Murthy | M. E. Kuenzig | J. McCurdy | S. Spruin | M. Carrier | Sanjay K. Murthy | Eric I Benchimol | Jeffrey D McCurdy | Geoffrey C. Nguyen
[1] Jason D. Wright,et al. Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] T. Ramsay,et al. A clinical predictive model for post‐hospitalisation venous thromboembolism in patients with inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.
[3] T. Card,et al. The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity , 2018, Alimentary pharmacology & therapeutics.
[4] J. Wong,et al. Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study. , 2018, Inflammatory bowel diseases.
[5] M. Di Nisio,et al. Incidental venous thromboembolism: is anticoagulation indicated? , 2017, Hematology. American Society of Hematology. Education Program.
[6] Subrata Ghosh,et al. Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study , 2017, The American Journal of Gastroenterology.
[7] M. Berry,et al. Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies , 2017, Journal of the National Cancer Institute.
[8] F. Klok,et al. Management of incidental pulmonary embolism , 2017, European Respiratory Journal.
[9] D. Baird,et al. Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis , 2016, Inflammatory bowel diseases.
[10] P. Higgins,et al. Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] G. Kaplan,et al. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. , 2015, World journal of gastroenterology.
[12] A. Forster,et al. Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. , 2014, Journal of clinical epidemiology.
[13] L. Dauchet,et al. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. , 2014, Journal of Crohn's & colitis.
[14] A. Griffiths,et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. , 2014, Gastroenterology.
[15] Elizabeth A. Scoville,et al. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] H. Yuhara,et al. Meta‐analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.
[17] G. Kaplan,et al. Postoperative complications following colectomy for ulcerative colitis: A validation study , 2012, BMC Gastroenterology.
[18] A. Griffiths,et al. Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements , 2012, The American Journal of Gastroenterology.
[19] L. Tamariz,et al. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data , 2012, Pharmacoepidemiology and Drug Safety.
[20] P. Austin. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.
[21] G. Nguyen,et al. Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review , 2011, The American Journal of Gastroenterology.
[22] J. West,et al. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.
[23] H. Tilg,et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.
[24] T. To,et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.
[25] Justina J. Sam,et al. Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.
[26] G. Kaplan,et al. A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.
[27] C. Huerta,et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.
[28] S. Danese,et al. Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.
[29] P. Austin,et al. The use of the propensity score for estimating treatment effects: administrative versus clinical data , 2005, Statistics in medicine.
[30] W. Reinisch,et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? , 2004, Gut.
[31] I. Brandslund,et al. Markers of Coagulation and Fibrinolysis as Measures of Disease Activity in Inflammatory Bowel Disease , 1998 .